Amgen, Adaptive Biotechnologies Expand Partnership on NGS Blood Cancer Monitoring Published on Sep 17, 2019  Aethlon Medical Lands $1.9M SBIR Grant for Exosome Isolation Device Published on Sep 16, 2019  MRSA Susceptibility Study Uncovers Protective Variant in Methyltransferase Published on Sep 16, 2019

Featured in Depth

Interoperability Network Helps Children's Hospitals Aggregate Genotype-Phenotype Data Published on Sep 16, 2019

Liquid Biopsy Uncovers Drug Resistance Mechanisms in GI Cancer Missed by Tissue Biopsy Published on Sep 16, 2019

Scope Fluidics Subsidiary Developing 15-Minute PCR System for POC Infectious Disease MDx Published on Sep 13, 2019

Natera Finds High Performance for Noninvasive Prenatal Test in All Age Groups Published on Sep 13, 2019

Live Webinar: Streamlined and High-Precision Cancer Analysis Using an Automated NGS Workflow in the Reference Lab Setting Dr. Raouf Ben Abdelali, head of the Hematology & Oncology division at Cerba Laboratory, will share how his team implemented an automated protocol for Agilent's SureSelect XT HS and SureSelect XT Low Input target enrichment technology. Register Now

Recommended for You

Australian Skin Cancer Genetic Study Seeks to Recruit 20K Additional Participants Published on Sep 16, 2019  India's 'Skeleton Lake' Yields Ancient Human Remains Spanning Diverse Populations, Time Points Published on Aug 20, 2019

Unlocking the Transcriptomic Potential of FFPE Cancer Samples: A Cross-Platform Comparison Study In this webinar, Dr. Arran K. Turnbull of the Cancer Research UK Edinburgh Center will discuss a study that compared nine different transcriptomic analysis technologies with matched fresh frozen (FF) and formalin-fixed paraffin-embedded (FFPE) cancer tissues. Register Here